High-purity therapeutic peptides, small molecule APIs, and customized chemical building blocks
An end-to-end B2B perspective on technical engineering, synthetic pathways, global regulatory compliance, and market dynamics.
Tesamorelin (CAS No. 218949-48-5 / 901758-09-6) represents a pinnacle of peptide engineering. As a stabilized, synthetic 44-amino acid analogue of Human Growth Hormone-Releasing Factor (GHRH), modified with a hexenoyl moiety at the N-terminus, Tesamorelin plays a critical therapeutic role in stimulating endogenous growth hormone synthesis. In global biopharmaceutical procurement, obtaining clinical-grade, cGMP-compliant Tesamorelin 5mg finished dosage vials or bulk API requires evaluating factory synthesis capabilities, purity verification through high-resolution analytical chromatography, lyophilization parameters, and strict control of related peptide impurities.
Tesamorelin selectively binds to and activates pituitary GHRH receptors, prompting the pulsatile release of somatotropins. Unlike exogenous HGH therapy, Tesamorelin preserves negative feedback loops, making it an indispensable API for clinical research into visceral adipose tissue (VAT) reduction, lipodystrophy, metabolic disorders, and age-related growth hormone degradation.
Manufacturing full-length 44-amino acid peptides like Tesamorelin requires eliminating truncation sequences and deletion peptides. Advanced factories implement hybrid Microwave-Assisted Solid-Phase Peptide Synthesis (SPPS) combined with fragment condensation strategies, maintaining coupling efficiencies above 99.5% per step.
Tesamorelin 5mg finished dosage forms are formulated via controlled freeze-drying cycles within class A cleanroom isolators. Protecting moisture levels (<1.0%), maintaining cake elegance, and minimizing trifluoroacetate (TFA) residual salts are mandatory parameters for robust shelf-life stability.
Standardized specification benchmarks for Tesamorelin 5mg raw material API and finished sterile lyophilized vials.
Industrial manufacturing of high-purity Tesamorelin requires careful optimization of solid support resins (such as Sieber amide or Rink amide resins), Fmoc/tBu protecting group chemistry, and efficient N-terminal coupling with (E)-hex-3-enoic acid. Below is an overview of the analytical standards strictly required by global contract development and manufacturing organizations (CDMOs).
| Analytical Parameter | Testing Methodology | Standard Technical Requirement | Industrial Quality Impact |
|---|---|---|---|
| Chemical Name | IUPAC Identification | (E)-hex-3-enoyl-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH2 | Verifies exact primary amino acid sequence. |
| Peptide Purity | RP-HPLC (Gradient Elution) | ≥98.0% (Clinical Standard ≥99.0%) | Prevents target receptor off-target activity and immunological responses. |
| Molecular Weight | ESI-MS / MALDI-TOF | 5135.9 ± 1.0 Da | Confirms correct peptide mass and complete deprotection. |
| Bacterial Endotoxins | LAL Chromogenic Assay | <0.05 EU/mg (API) / <5 EU/vial | Mandatory compliance for parenteral administration security. |
| Residual Solvents | GC-HS (Headspace GC) | Meets ICH Q3C Limits (Acetonitrile <410ppm, DMF <880ppm) | Eliminates toxic synthesis byproducts from finished vials. |
| Counter-Ion Content | Ion Chromatography / HPLC | Acetate ≤12% or TFA ≤1.0% | Controls pH balance during reconstitution and prevents local injection site irritation. |
| Sterility & Bioburden | Direct Inoculation / Membrane Filtration | Sterile (No microbial growth after 14 days) | Ensures long-term integrity of 5mg lyophilized finished product vials. |
Modern Tesamorelin factory facilities utilize continuous flow peptide synthesizers. By monitoring real-time UV absorption during Fmoc deprotection steps and optimizing coupling temperature profiles (between 45°C and 60°C), manufacturers mitigate racemization—specifically preventing the conversion of L-methionine, L-aspartic acid, and L-phenylalanine to their D-enantiomeric impurities.
Navigating regulatory filings, cold-chain logistics, and bulk B2B commercial agreements.
Commercializing Tesamorelin requires robust Drug Master File (DMF) submissions to the US FDA (21 CFR Part 210/211 cGMP) and European Medicines Agency (EMA) Common Technical Documents (CTD). Procurement entities must ensure manufacturers supply complete ICH stability data (Zone II and Zone IVb testing).
Tesamorelin is sensitive to thermal degradation and oxidation. Standard industrial distribution workflows mandate insulated packaging with calibrated temperature loggers maintaining conditions between -20°C (bulk powder) and 2°C to 8°C (lyophilized 5mg vials) throughout international freight transit.
Leading chemical and pharmaceutical enterprises offer flexible supply contracts—ranging from gram-scale custom research batches to kilogram-scale commercial API supply and Finished Dosage Form (FDF) contract manufacturing under private label arrangements.
Connecting the world with high-purity peptides, APIs, and complete manufacturing solutions.
Gentolex’s goal is to create opportunities connecting the world with better services and guaranteed products. Up to date, Gentolex Group has been serving customers from more than 10 countries, specially, representatives are established in Mexico and South Africa.
Our main services focus on supplying peptides APIs and Custom Peptides, FDF license out, Technical Support & Consultation, Product Line and Lab Setup, Sourcing & Supply Chain Solutions.
An overall factory construction area of 250,000 square meters under international standard allows us to offer flexible, scalable, and cost-effective solutions for clients globally.
An overall factory construction area of 250,000 square meters under international standard to offer flexible, scalable and cost-effective chemical synthesis solutions.
Gentolex offers an extensive range of APIs and intermediates for development study and commercial application with cGMP standard from long-term collaborations. Full documentation and certificates are supported worldwide.
Process optimization, peptide sequence modification, impurities profiling, analytical method validation, and technology transfer tailored to customer specifications.
For clients who prefer to avoid the complexity of dealing with multiple points of contact, we provide customized procurement services leveraging superior supply chain networks.
Trusted by pharmaceutical leaders, biotech innovators, and institutional research organizations worldwide.
Industry insights, technical breakthroughs, and product updates from our peptide research division.
Introduction to Selank Acetate API: Selank Acetate API is a synthetic heptapeptide active pharmaceutical ingredient (API) composed of the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro (TKPRPGP). Derived from endogenous tuftsin...
View Details
Trusted Thymosin Beta-4 API Manufacturer and Global Peptide Supplier: As a professional Thymosin Beta-4 API manufacturer and supplier, we provide high-quality Thymosin Beta-4 peptide API solutions for biotechnology companies...
View Details
BPC-157 API is a synthetic pentadecapeptide that has gained increasing attention in peptide research due to its potential biological activities related to tissue repair, gastrointestinal protection, and cellular signaling...
View Details
With the continuous development of neuroscience, peptide technology, and life science research, neuroactive peptides have become an important area. Semax, a synthetic peptide derived from an ACTH fragment...
View Details
SS-31 API, also known as Elamipretide, MTP-131, Bendavia, and SS31, is a synthetic mitochondria-targeting tetrapeptide designed to bind cardiolipin in the inner mitochondrial membrane, supporting cellular bioenergetics...
View DetailsDirect insights regarding Tesamorelin 5mg factory capabilities, quality assurance, regulatory documentation, and order fulfillment.
High-demand active pharmaceutical ingredients, custom building blocks, and cosmetic peptides.
